Affiliation: Ventera Bio

Steve is a co-founder and chief scientific officer of Ventera Bio Ltd, UK. He is a venom peptide expert with more than 16 years of experience and previously served as founder and chief scientific officer of Venomtech Ltd, where he focused on targeting venom peptides to protein targets, including those implicated in cancer. At Venomtech, he pioneered the Targeted Venom Discovery Array (T-VDA™), a platform used to screen numerous cancer-related targets. At Ventera Bio, he leads scientific efforts to develop novel venom-derived peptide biopesticides.

Prior to founding Venomtech, Steve worked as a drug discovery biologist at Pfizer for 10 years, where he developed expertise in research and drug development. He also serves as chair of the Veterinary Invertebrate Society and the SLAS Automation and Screening in Agri-Tech Topic Interest Group (TIG). Steve is the lead inventor on several peptide-related patents, including technologies for rodenticides and insecticides.